CEN Biotech, Inc.
CEN Biotech, Inc. (CENBF) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001653821 · CENBF · OTC · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001653821 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
No recent filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
CEN Biotech, Inc. (OTC: CENBF) has submitted 189 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2020. As a Healthcare sector company with CIK 0001653821, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is CEN Biotech, Inc.'s most comprehensive regulatory disclosure. The most recent CEN Biotech, Inc. 10-K was filed on 2022-04-14 for fiscal year ending 2022. Historical CENBF 10-K annual reports are available from 2015 through 2022.
Investors researching CEN Biotech, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
CENBF SEC Filings · 8 questionsCEN Biotech, Inc. (CENBF) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 189 filings and access original documents at no cost. CEN Biotech, Inc.'s CIK is 0001653821.